September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Effect of panretinal photocoagulation on intravitreal levels of neurotrophins in diabetic retinopathy
Author Affiliations & Notes
  • Joseph Daniel Boss
    Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States
  • Pawan Kumar Singh
    Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States
  • Joaquin Tosi
    Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States
  • Hemang Pandya
    Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States
    Dean McKee Eye Institute, Oklahoma City, Oklahoma, United States
  • Asheesh Tewari
    Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States
  • Ashok Kumar
    Ophthalmology, Kresge Eye Institute, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Joseph Boss, None; Pawan Kumar Singh, None; Joaquin Tosi, None; Hemang Pandya, None; Asheesh Tewari, None; Ashok Kumar, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5443. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Joseph Daniel Boss, Pawan Kumar Singh, Joaquin Tosi, Hemang Pandya, Asheesh Tewari, Ashok Kumar; Effect of panretinal photocoagulation on intravitreal levels of neurotrophins in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5443.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy is a disease of progressive vascular-neurodegeneration. The neurotrophin (NT) family includes nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4). NT are a group of growth factors that play a critical role in the development, survival, maintenance, and repair of the nervous system, as well as play essential roles in angiogenesis and fibrosis. Intraocular neurotrophins influence local vascular endothelial growth factor (VEGF) levels. We assayed the human vitreous in an attempt to further investigate the effect of peripheral retina ablation with PRP on the levels of intravitreal neurotrophins in diabetic retinopathy.

Methods : Prospective study with 15 patients with diabetic retinopathy, of which 9 had a history of previous PRP. The indications for vitrectomy were rhegmatogenous and tractional retinal detachment, non-clearing vitreous hemorrhage, and epiretinal membrane peel. Undiluted vitreous samples were collected and frozen in liquid nitrogen during transfer to a -80°C freezer until assay. Quantitative analysis was determined using neurotrophins ELISA (R & D System, Minneapolis, MN).

Results : Nine (60%) vitreous samples were collected from eyes with a history of PRP, and six (40%) control samples were from eyes without a history of PRP. The average patient age was 60.6 years (Range: 42-78). Our quantitative data (Table 1) indicates no change overall in expression of NT in the human vitreous in diabetic eyes with a history of PRP compared to eyes without a history of PRP.

Conclusions : Our study reinforced the presence of NT in the human vitreous in diabetic retinopathy, and highlights the lack of effect that PRP has on NT levels in diabetic retinopathy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×